Faculty & Staff
Kevin B. Kiser, Lecturer
Ph.D., Molecular & Cellular Biology and Pathobiology, Medical University of South Carolina, Charleston, SC, 1996
B.A, Biology, Boston University, Boston, MA, 1990
Osprey Hall 2020C | (910) 962-2698 | 601 South College Road, Wilmington, NC, 28403-5915
email@example.com | http://people.uncw.edu/kiserk
Three active areas of study in my lab include: 1) MRSA Carriage in Nursing Students. With assistance from the School of Nursing (SON), DIS students are trackingS.aureuscarriage in UNCW Pre-Nursing and Nursing students to determine the impact of clinical exposure on developing carriage; 2) STIs in At-Risk College Students. A urine-based PCR assay has been developed by DIS students to test s UNCW students visiting the Abrons Student Health Center (SHC) for free HIV testing for asymptomatic chlamydia and gonorrhea infections; 3) Antibiotic Discovery. DIS students in my laboratory are testing antibiotic activities of synthetic compounds produced by DIS students in the lab of Dr. Thomas Coombs (UNCW Department of Chemistry and Biochemistry), where they engage in the development of new chemical methods for synthesizing medicinal and biologically-active compounds. Furthermore, my DIS students are seeking natural sources of antibiotics in soil samples collected from unique local environments with the goal of crowdsourcing the discovery of antibiotics. In addition to exploring relevant issues in health and medicine, the mission of my lab is to provide research opportunities and applied learning experiences for undergraduate students and to foster interdepartmental collaborations at UNCW. Please visit my research website for more information (http://people.uncw.edu/kiserk).
Kiser K. Microbiology of Human Diseases: Laboratory Techniques and Applications. Dubuque, IA: Kendall Hunt Publishing Company, 2014. Print.
Kiser K. Applying the Tools of the Microbiologist. Dubuque, IA: Kendall Hunt Publishing Company, 2011. Print.
Portoles M, Kiser KB, Bhasin N, Chan KHN, Lee JC. 2001. Staphylococcus aureus Cap5O has UDP-ManNAc dehydrogenase activity and is essential for capsule expression. Infection and Immunity. 69:917-923.
Pohlmann-Dietze P, Ulrich M, Kiser KB, Doring G, Lee JC, Fournier J-M, Botzenhart K, Wolz C. 2000. Adherence of Staphylococcus aureus to endothelial cells: Influence of the bacterial growth phase, the global regulator agr and capsular polysaccharide. Infection and Immunity. 68:4865-4871.
Schmidt MG, Kiser KB. 1999. SecA: The ubiquitous component of preprotein translocase in prokaryotes [Review]. Microbes & Infection. 1:993-1004.
Kiser KB, Cantey-Kiser JM, Lee JC. 1999. Development and characterization of a Staphylococcus aureus nasal colonization model in mice. Infection and Immunity. 67:5001-5006.
Kiser KB, Bhasin N, Deng L, Lee JC. 1999. Staphylococcus aureus cap5P encodes a UDP-N-acetylglucosamine 2-epimerase with functional redundancy. Journal of Bacteriology. 181:4818-4824.
Kiser KB, Schmidt MG. 1999. Regulation of the Escherichia coli secA gene is mediated by two distinct RNA structural conformations. Current Microbiology. 38:113-121.
Kiser KB, Lee JC. 1998. Staphylococcus aureus cap5O and cap5P genes functionally complement mutations affecting enterobacterial common-antigen biosynthesis in Escherichia coli. Journal of Bacteriology. 180:403-406.
Kiser KB, Arnaud P, Schmidt MG. 1994. Rapid purification of native SecA from Escherichia coli: Development of a new affinity chromatography procedure. Current Microbiology. 29:323-329.